Volume : 11, Issue : 09, September – 2024
Title:
FORMULATION AND EVALUATION TOPICAL GEL OF ONDANSETRON
Authors :
Aarthi patil, Dr. Nazemoon
Abstract :
Objective: This study aimed to formulate and evaluate a topical gel containing ondansetron, a potent antiemetic, to explore its potential as an alternative delivery system for managing nausea and vomiting.
Methods: Ondansetron topical gel was formulated using various gelling agents and excipients to optimize its physicochemical properties. The formulations were evaluated for gel consistency, pH, drug content, in vitro drug release.
Results: The developed topical gels exhibited suitable consistency and pH levels, with optimal drug content uniformity. In vitro release studies indicated a controlled release profile, supporting sustained drug delivery.
Conclusion: The ondansetron topical gel formulations were successfully developed, demonstrating desirable properties such as sustained release and minimal skin irritation. This alternative delivery system holds promise for improving patient compliance and comfort in the management of nausea and vomiting.
Keywords: Ondansetron Topical Gel , HPMC, Sodium Cmc and Carbopol-934
Cite This Article:
Please cite this article in press Aarthi patil et al Formulation And Evaluation Topical Gel Of Ondansetron.,Indo Am. J. P. Sci, 2024; 11 (09).
Number of Downloads : 10
References:
1. Payer M, Barel AO, Maibach HI. Handbook of cosmetic science and technology. 2nd edn. New York. CRC Press. 2006.
2. Robinson JR and Lee VHL. Controlled Drug Delivery, 2nd edn., Vol. 29. Marcel Dekker, Inc., Madison Avenue , New York, 524-526.
3. Breggi SR, Pirola R, De-Beneditis G. Comparison between topical aspirin and oral aspirin in acute herpes zoster. Eur. J. Clin. Pharmacol 1998; 54: 231-235.
4. Lachman L and Lieberman IA. The Theory and Practice of Industry Pharmacy, 3rd edn., Varghese Publishing house, 1991, 536-537.
5. Buhse L, Kolinski R, Westenberger B, Wokovich A, Spencer J, Chen CW, Turujman S, Basak MG, Kang GJ, Kibbe J, Heintzelman B, Wolfgang E. Topical drug classification. Int J Pharm 2005; 295: 101-112.
6. www.drugdeliverypartnerships/synder.html
7. Monti D, Salettone MF, Giannaccini B, Galli-Angeli D. Enhancement of transdermal penetration of dapiprazole through mouse skin. J. Control Rel. 1995; 33: 71-77.
8. Banker GS and Rhodes CT. Modern Pharmacist. 2nd edn. Marcel Dekker, Inc., Madison Avenue. New York, 1990; 40: 302-308.
9. Ansel HC, Popovich NC and Allen LV. Pharmaceutical Dosage forms and drug delivery systems. 8th edn. B.I Publications Pvt Ltd. 2005; 418.
10. Penna LE. Gel dosage farms: Theory, formulation and processing: In topical drug delivery formulation. (Ashorn WH and Amann AH). Marcel Dekker Inc. New York. 1990; 381-388.
11.Artaiz I, Zazpe A, Del Rio J: Characterization of serotonergic mechanisms involved in the behavioural inhibition induced by 5-hydroxytryptophan in a modified light-dark test in mice. Behav Pharmacol. 1998 Mar;9(2):103-12.
12.Fortuno A, Ballaz S, Del Rio J, Barber A: CCK-mediated response in the activation of 5-HT receptor types in the guinea-pig ileum. J Physiol Biochem. 1999 Jun;55(2):85-92.